Top Medical News
Elvira Manzano, 4 days ago
The anthelmintic agent ivermectin, tested in the EPIC* trial of 476 patients, did not significantly shorten symptom duration in adults with mild COVID-19.
06 Apr 2021
Excision with narrow margins does not predict mortality or recurrence in patients with Merkel cell carcinoma, results of a study have shown. Residual tumour, found primarily on deep surgical margins, is independently associated with prognosis.
05 Apr 2021
Use of hydroxychloroquine (HCQ) is inversely associated with the risk of cardiovascular events in patients with lupus erythematosus (LE), as indicated by the results of a recent study.
Stephen Padilla, 31 Mar 2021
Hospitalized adults with COVID-19, as opposed to those with other acute viral infections, normally present with mucocutaneous eruptions, which may indicate a more severe course of illness, suggests a recent study.
Elvira Manzano, 24 Mar 2021
The oral Janus kinase (JAK) inhibitor abrocitinib, otherwise called jakinib, does well in patients 12–17 years of age with atopic dermatitis (AD) in the phase III JADE TEEN study, providing instant itch relief.
Stephen Padilla, 15 Mar 2021
Tedizolid is a safe and effective treatment option for adolescents with acute bacterial skin and skin structure infections (ABSSSIs), particularly those with S. aureus-susceptible strains, a study has shown.
15 Mar 2021
Several comorbidities associated with psoriasis vulgaris are also prevalent in patients with plaque palmoplantar psoriasis (PPP), a recent study has found. In addition, individuals with PPP have a particularly high risk for mood disorders.
Special Reports
10 Dec 2019
Oral H1-antihistamines are the initial treatment of choice for allergic rhinitis (AR) and chronic urticaria in the primary care setting. However, in a diverse population of patients with AR and urticaria, primary care physicians are faced with the challenge of prescribing the best therapy amid a wide armamentarium of antihistamines available.
22 Oct 2019
Topical silicone gel is considered first-line therapy against scars and is used particularly for the treatment of elevated scars,such as hypertrophic and keloid scars. In this report, Dr Yong shares his clinical experience of using silicone gel as part of his scar management strategies.
26 Mar 2019
Sunscreen products commonly contain only filters against ultraviolet (UV) radiation. At a recentdinner symposium organized by Eucerin, Dr Rungsima Wanitphakdeedecha discussed whythis is insufficient and what is required for effective protection against the damaging effects ofsunlight on the skin
01 Nov 2018
The prevalence of allergic diseases in the Asia-Pacific region is expected to rise over the next 20 years, driven by rapid economic development and urbanization. Allergic diseases have high socioeconomic impact by impairing productivity and quality of life, and the impact may be greater in Asia-Pacific than in Europe due to the presence and predominance of perennial allergens.
31 Jul 2018
A wound is a disruption of the normal structure and function of the epidermis. Wounds maybe caused by acute traumatic injury to the skin, or other aetiologies that cause initially intact skin to break down. Recently, Dato’ Dr Ho Teik Kok shared his insights into the importance of micronutrients for wound recovery, stressing on the importance of treating the underlying diseases that may impede wound healing.
Dr. Steven Ang, Dr. Leo Kah Woon, 11 Jul 2018
DCH Auriga recently held their first Aesthetics and Suturing Workshop under the IMPACT continuing medical education series – a scientific platform that aims to cascade the latest updates on disease management and share best clinical practices among healthcare professionals in Singapore. Two experts on aesthetics and aesthetic surgery shared their insights on suturing techniques and current approaches for scar prevention and management.
Conference Reports
Roshini Claire Anthony, 16 Dec 2020

Upadacitinib monotherapy improved symptoms and quality of life (QoL) in adolescents and adults with moderate-to-severe atopic dermatitis (AD), according to the phase III Measure Up 1 and 2 studies presented at EADV 2020.

Elaine Soliven, 04 Dec 2020
Treatment with low-dose (LD) or high-dose (HD) secukinumab significantly improved Psoriasis Area and Severity Index (PASI)* scores in paediatric patients with severe chronic plaque psoriasis, according to a study presented at EADV 2020.
Pearl Toh, 24 Nov 2020
A topical gel treatment derived from birch bark significantly speeds up wound healing compared with standard care in patients with epidermolysis bullosa (EB) lesions, according to the EASE trial presented at the EADV 2020 Conference — representing the first-ever treatment to show positive results for the rare skin disorder.
Elaine Soliven, 24 Nov 2020
Treatment with apremilast led to significantly improved patient-reported quality of life (QoL) outcomes in patients with moderate-to-severe plaque psoriasis of the scalp, according to the STYLE* study presented at EADV 2020.
Audrey Abella, 19 Nov 2020
Socks coated with zinc oxide nanoparticles (ZnO-NPs), a suitable textile additive, were effective in preventing bromodosis and the development of pitted keratolysis (PK), a Thai study suggests.
Roshini Claire Anthony, 18 Nov 2020

The efficacy of tildrakizumab in chronic moderate-to-severe* plaque psoriasis is maintained after 5 years of treatment, final pooled analyses of the phase III reSURFACE 1 and reSURFACE 2 trials showed.

Stephen Padilla, 13 Nov 2020
The modified glutathione (GSH-C4) with beta glycyrrhetic and azelaic acids cream is effective in the treatment of mild-to-moderate rosacea, with local tolerability consistent with other antirosacea medications, according to a study presented at the 29th Congress of the European Academy of Dermatology and Venereology (EADV 2020).